133 related articles for article (PubMed ID: 27762592)
1. Fibrin nanostructures for biomedical applications.
Riedelová-Reicheltová Z; Brynda E; Riedel T
Physiol Res; 2016 Oct; 65(Suppl 2):S263-S272. PubMed ID: 27762592
[TBL] [Abstract][Full Text] [Related]
2. Controlled preparation of thin fibrin films immobilized at solid surfaces.
Riedel T; Brynda E; Dyr JE; Houska M
J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
[TBL] [Abstract][Full Text] [Related]
3. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study.
Jung H; Tae G; Kim YH; Johannsmann D
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):111-9. PubMed ID: 19004623
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial cells on two-and three-dimensional fibrin assemblies for biomaterial coatings.
Filová E; Brynda E; Riedel T; Bacáková L; Chlupác J; Lisá V; Houska M; Dyr JE
J Biomed Mater Res A; 2009 Jul; 90(1):55-69. PubMed ID: 18481789
[TBL] [Abstract][Full Text] [Related]
5. Controlling Fibrin Network Morphology, Polymerization, and Degradation Dynamics in Fibrin Gels for Promoting Tissue Repair.
Sproul EP; Hannan RT; Brown AC
Methods Mol Biol; 2018; 1758():85-99. PubMed ID: 29679324
[TBL] [Abstract][Full Text] [Related]
6. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
Hogg PJ; Jackson CM
Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
[TBL] [Abstract][Full Text] [Related]
7. Fibrin-Based Biomaterial Applications in Tissue Engineering and Regenerative Medicine.
Park CH; Woo KM
Adv Exp Med Biol; 2018; 1064():253-261. PubMed ID: 30471038
[TBL] [Abstract][Full Text] [Related]
8. A novel fibrin gel derived from hyaluronic acid-grafted fibrinogen.
Yang CL; Chen HW; Wang TC; Wang YJ
Biomed Mater; 2011 Apr; 6(2):025009. PubMed ID: 21393811
[TBL] [Abstract][Full Text] [Related]
9. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
Mosesson MW; Hernandez I; Siebenlist KR
Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lipid Surface Composition on the Formation and Structure of Fibrin Clots.
Bakirova DR; Faizullin DA; Valiullina YA; Salnikov VV; Zuev YF
Bull Exp Biol Med; 2017 Oct; 163(6):722-725. PubMed ID: 29063338
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured Surfaces That Mimic the Vascular Endothelial Glycocalyx Reduce Blood Protein Adsorption and Prevent Fibrin Network Formation.
Hedayati M; Reynolds MM; Krapf D; Kipper MJ
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31892-31902. PubMed ID: 30156830
[TBL] [Abstract][Full Text] [Related]
12. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
13. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI
Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548
[TBL] [Abstract][Full Text] [Related]
14. The interactions between antithrombin III, thrombin and surface immobilized heparin.
van Delden CJ; Engbers GH; Feijen J
J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
[TBL] [Abstract][Full Text] [Related]
15. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
[TBL] [Abstract][Full Text] [Related]
16. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
17. Magnetically-guided self-assembly of fibrin matrices with ordered nano-scale structure for tissue engineering.
Alsberg E; Feinstein E; Joy MP; Prentiss M; Ingber DE
Tissue Eng; 2006 Nov; 12(11):3247-56. PubMed ID: 17518638
[TBL] [Abstract][Full Text] [Related]
18. Fibrin: a versatile scaffold for tissue engineering applications.
Ahmed TA; Dare EV; Hincke M
Tissue Eng Part B Rev; 2008 Jun; 14(2):199-215. PubMed ID: 18544016
[TBL] [Abstract][Full Text] [Related]
19. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
[TBL] [Abstract][Full Text] [Related]
20. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.
Jeon O; Ryu SH; Chung JH; Kim BS
J Control Release; 2005 Jul; 105(3):249-59. PubMed ID: 16088988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
